PMID: 2115753Aug 1, 1990Paper

Screening for cervical cancer

Annals of Internal Medicine
D M Eddy

Abstract

Indirect evidence indicates that cervical cancer screening should reduce the incidence and mortality of invasive cervical cancer by about 90%. In the absence of screening, a 20-year-old average-risk woman has about a 250 in 10,000 chance of developing invasive cervical cancer during the rest of her life, and about a 118 in 10,000 chance of dying from it. Screening at least every 3 years from 20 to 75 years of age will decrease these probabilities by about 215 in 10,000 and 107 in 10,000, respectively, and will increase a 20-year-old woman's life expectancy by about 96 days. The particular age at which screening is begun (for example, 17 or 20 years), the requirement of several initial annual examinations before reducing the frequency, and screening every 1 or 2 years compared with every 3 years improves the effectiveness by less than 5%. Screening is recommended at least every 3 years from about age 20 to about age 65 years.

Citations

Nov 25, 1997·Journal of Surgical Oncology·F E Johnson
Jun 1, 1995·Diagnostic Cytopathology·G K NagyL E Newton
Oct 25, 2002·International Journal of Cancer. Journal International Du Cancer·Loraine D MarrettSilvana Luciani
Oct 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·A M ParfittM Kleerekoper
Mar 1, 1992·Cancer Causes & Control : CCC·L Gustafsson, H O Adami
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·S Broder
Apr 1, 1996·Journal of Community Health·J H PriceP B Wallace
May 1, 1996·Journal of General Internal Medicine·A B BindmanA L Stewart
Dec 23, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Faridah Djellal, Faïz Gallouj
Oct 9, 2008·Bulletin of Mathematical Biology·Elamin H ElbashaRalph P Insinga
Feb 23, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A ValencianoP C Lara
Oct 1, 1992·Journal of Psychosomatic Research·J Wardle, R Pope
Dec 18, 2013·Gynecologic Oncology·Jennifer L MossNoel T Brewer
Feb 1, 2000·The American Journal of Medicine·J B Wong
Nov 9, 2002·Obstetrics and Gynecology·Anne-Marie E AmiesLaura Koutsky
Oct 9, 1998·Obstetrics and Gynecology·J MelnikowL P Howell
Jun 24, 1995·Lancet·C Patterson, L W Chambers
Jan 7, 1997·Journal of Health Economics·A M Garber, C E Phelps
Jan 7, 1997·Journal of Health Economics·D Meltzer
Oct 27, 1999·Journal of the American Academy of Dermatology·K A FreedbergH K Koh
Apr 18, 2001·American Journal of Preventive Medicine·S SahaUNKNOWN Cost Work Group, Third US Preventive Services Task Force
Apr 13, 1999·American Journal of Preventive Medicine·M L MessonnierJ R Harris
Jul 1, 1996·Nutrition·C S Roehrig, J A Lee
Nov 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M van BallegooijenF Habbema
Apr 9, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A B BosJ D F Habbema
Feb 19, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J L Wolstenholme, D K Whynes
Apr 1, 2000·Journal of Pediatric and Adolescent Gynecology·C A GerhardtS L Rosenthal
Nov 4, 2000·Clinical Cornerstone·R E Bristow, F J Montz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved